Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

Clinical trial NCT06350630 · RECRUITING

Trial details

NCT number: NCT06350630
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2025-06-26
Primary completion: 2027-12-31
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.